Postoperative Outcomes of Mitral Valve Repair in Patients with Bileaflet Prolapse
Öz
Background
Today, repair techniques almost completely take place of the mitral valve replacement, especially in patients with degenerative disease. Majority of the surgeons hesitate to prefer repair in patients with bileaflet prolapse. In this study we aimed to investigate postoperative results of our patients with mitral valve insufficiency due to bileaflet prolapse and treated with repair techniques
Methods
89 patients who underwent mitral valve repair by the same surgical team due to bileaflet prolapse, between January 2006 and January 2016 in Turkiye Yuksek Ihtisas Hospital were included to this study. Preoperative, operative and postoperative data such as mortality, recurrent mitral insufficiency, echocardiographic parameters and reoperation rates were investigated.
Results
Mean follow up duration was 25.3±17.7 months. Mean age was 46.6±17.4 years. According to the transthoracic echocardiographic evaluations, 8 (9%) patients had moderate and 81 (91%) patients had severe mitral insufficiency. When preoperative and postoperative values were compared statistically significant improvement in functional capacity of patients according to NYHA classification has been noted. (2.1±0.5 ; 1, , p=0.001) Improvements in left ventricular end diastolic diameter (5.5±0.7 cm ; 5±0.6 cm, p=0.001), left ventricular end sistolic diameter (3.8±0.6 cm ; 3.6±0.6 cm, p=0.004 ), left atrium diameter (4.8±0.9 cm ; 4.3±0.6 cm, p=0.001) and pulmonary artery pressure (44.3±13.4 mmHg; 32.1±5.4 mmHg, p=0.001) were statistically significant.
Conclusions
In the lights of findings about good postoperative results and durability rates, mitral valve repair can be safely used in patients with mitral valve insufficiency due to bileaflet prolapse especially with chordae replacement technique which can be feasible after improvements in suture technologies.
Anahtar Kelimeler
Kaynakça
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. 2014 AHA/ ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American Heart Association Task Force on practice guidelines. Circulation 2014;129:2440–92.
- Sand ME, Naftel DC, Blackstone EH et al. A comparison of repair and replacement for mi- tral valve incompetence. J Thorac Cardiovasc Surg 1987;94:208.
- Tribouilloy C, Enriquez-Sarano M, Schaff H et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation : rationale for optimizing surgical indications. Circulation 1999;99:400–5
- Suri RM, Schaff H, Dearani JA et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 2006;82:819–26.
- Gillinov A, Cosgrove D, Blackstone E et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116:734–43.
- Rankin JS, Orozco RE, Rodgers TL, Alfery DD, Glower DD. ‘‘Adjustable’’ artificial chordal replacement for repair of mitral valve prolapse. Ann Thorac Surg 2006;81:1526-8.
- Lawrie GM, Earle EA, Earle NR. Feasibility and intermediate term outcome of repair of prolapsing anterior mitral leaflets with artificial chordal replacement in 152 patients. Ann Thorac Surg 2006;81:849–56.
- Hataa H, Fujitaa T, Shimaharaa Y, Satoa S, Ishibashi-Uedab H and Kobayashia J. A 25-year study of chordal replacement with expanded polytetrafluoroethylene in mitral valve repair. Interactive CardioVascular and Thoracic Surgery 2015;20:463–9
- Lung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
- Jokinen JJ, Hippelainen MJ, Pitkanen OA, Hartikainen JE. Mitral valve replacement versus repair: propensity-adjusted survival and quality-of-life analysis. Ann Thorac Surg 2007; 84:451-8